January 20, 2015 | The Israeli company providing contact-free patient monitoring, EarlySense, announced that it completed a $20 million financing round. The round was led by Samsung Ventures, which invested $10 million of the amount, along with Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber. EarlySense is a medical device company based in Ramat Gan, Israel that develops patient monitoring systems. The company is currently headed by CEO Avner Halperin.
Related posts
Israeli Cybersecurity Startup To Provide Training For IDF
October 10, 2024
Johnson & Johnson Completes Purchase Of Israeli Startup V-Wave
October 10, 2024
Weizmann Researchers Create Biodegradable Composite Plastic
October 09, 2024
IIA Funds Further Israeli R&D Into Crustacean Gene Modification
October 09, 2024
Facebook comments